A detailed history of Payden & Rygel transactions in Amgen Inc stock. As of the latest transaction made, Payden & Rygel holds 35,200 shares of AMGN stock, worth $11.1 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
35,200
Previous 5,300 564.15%
Holding current value
$11.1 Million
Previous $1.42 Million 672.33%
% of portfolio
0.89%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 07, 2024

BUY
$262.75 - $319.31 $7.86 Million - $9.55 Million
29,900 Added 564.15%
35,200 $11 Million
Q1 2024

Oct 08, 2024

BUY
$268.87 - $324.56 $6.1 Million - $7.37 Million
22,700 Added 64.49%
57,900 $16.5 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $1.36 Million - $1.53 Million
5,300 New
5,300 $1.53 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $15.7 Million - $19.1 Million
69,440 Added 6312.73%
70,540 $17.1 Million
Q1 2022

Apr 13, 2022

SELL
$219.27 - $242.57 $22.2 Million - $24.5 Million
-101,040 Reduced 98.92%
1,100 $266,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $6.7 Million - $7.67 Million
-33,700 Reduced 24.81%
102,140 $23 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $806,626 - $945,060
3,800 Added 2.88%
135,840 $28.9 Million
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $537,234 - $596,022
-2,300 Reduced 1.71%
132,040 $32.2 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $454,915 - $530,130
2,050 Added 1.55%
134,340 $33.4 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $12.5 Million - $13.9 Million
53,440 Added 67.77%
132,290 $33.6 Million
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $336,277 - $412,658
1,700 Added 2.2%
78,850 $18.6 Million
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $13.9 Million - $18.5 Million
76,500 Added 11769.23%
77,150 $15.6 Million
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $2.21 Million - $2.65 Million
-12,680 Reduced 95.12%
650 $126,000
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $23.3 Million - $26.2 Million
-128,600 Reduced 90.61%
13,330 $2.53 Million
Q4 2018

Jan 25, 2019

BUY
$178.4 - $208.25 $2.32 Million - $2.7 Million
12,980 Added 10.07%
141,930 $27.6 Million
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $1.2 Million - $1.36 Million
-6,500 Reduced 4.8%
128,950 $26.7 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $66,420 - $74,604
400 Added 0.3%
135,450 $25 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $6.39 Million - $7.46 Million
37,700 Added 38.73%
135,050 $23 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $2.28 Million - $2.55 Million
13,500 Added 16.1%
97,350 $16.9 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $14 Million - $16 Million
83,850
83,850 $15.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Payden & Rygel Portfolio

Follow Payden & Rygel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.